corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 17051

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Dyer C
Professor is charged with dishonesty over statements on access to full trial data
BMJ 2009 Nov 3;
http://www.bmj.com/cgi/content/extract/339/nov03_2/b4556


Abstract:

The former research dean of Sheffield University’s medical school was accused of dishonesty at a General Medical Council hearing on 2 November for allowing a journal to publish a false claim that he had seen all the data in a research study of which he was the lead author.

Richard Eastell, who heads the bone research unit at Sheffield University, is at the centre of a research ethics case that saw the other main investigator, Aubrey Blumsohn, who raised questions over the data, take a financial settlement to leave his job at the university.

Dr Blumsohn says that he and Professor Eastell both asked Procter & Gamble, which was funding the study into its osteoarthritis drug risedronate (Actonel), for access to the full data but were refused. The university had been asked to carry out measurements on blood and urine samples that had been taken during clinical trials in the . . .

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.